Focal salvage Iodine-125 brachytherapy for recurrent prostate cancer after primary radiotherapy

被引：0
|
作者：
Peters, M. [1 ]
Maenhout, M. [1 ]
Van Zyp, J. R. N. van der Voort [1 ]
Moerland, M. A. [1 ]
Moman, M. [2 ]
Van der Heide, U. A. [3 ]
Steuten, L. M. G. [4 ]
Battermann, J. J. [1 ]
Van Deursen, M. J. H. [1 ]
Van Vulpen, M. [1 ]
机构：
[1] UMC Utrecht, Radiotherapy, Utrecht, Netherlands
[2] UMC Utrecht, Radiol, Utrecht, Netherlands
[3] Netherlands Canc Inst, NKI, Amsterdam, Netherlands
[4] Univ Twente, Dept Hlth Technol & Serv Res, Enchede, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0072
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
    Celada, F.
    Chicas, R.
    Soler, A.
    Roldan, S.
    Candela, C.
    Gimeno, J.
    Tormo, A.
    Perez-Calatayud, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S679
  • [2] Salvage Iodine-125 Seed Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiotherapy
    Smith, D.
    Maclean, J. D.
    Plowman, P. N.
    [J]. CLINICAL ONCOLOGY, 2009, 21 (03) : 249 - 249
  • [3] Salvage brachytherapy with iodine 125 in local prostate cancer recurrence after primary radiotherapy
    Zimmermann, J.
    Osieka, R.
    Sablotny, J.
    Bruns, T.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 226 - 226
  • [4] Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life
    Peters, Max
    Maenhout, Metha
    van Zyp, Jochem R. N. van der Voort
    Moerland, Marinus A.
    Moman, Maaike R.
    Steuten, Lotte M. G.
    van Deursen, Marijke J. H.
    van Vulpen, Marco
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 112 (01) : 77 - 82
  • [5] Rectal dose constraints for total and focal salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Westendorp, H.
    Kattevilder, R.
    Van de Pol, S. M.
    Maenhout, M.
    Van Vulpen, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S64 - S65
  • [6] A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S28 - S29
  • [7] Comparative cost-effectiveness of focal and total salvage 125I brachytherapy for recurrent prostate cancer after primary radiotherapy
    Peters, Max
    Piena, Marjanne A.
    Steuten, Lotte M. G.
    van Zyp, Jochem R. N. van der Voort
    Moerland, Marinus A.
    van Vulpen, Marco
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2016, 8 (06) : 484 - 491
  • [8] Rectal dose constraints for salvage iodine-125 prostate brachytherapy
    Peters, Max
    Hoekstra, Carel J.
    van Zyp, Jochem R. N. van der Voort
    Westendorp, Hendrik
    van de Pol, Sandrine M. G.
    Moerland, Marinus A.
    Maenhout, Metha
    Kattevilder, Rob
    van Vulpen, Marco
    [J]. BRACHYTHERAPY, 2016, 15 (01) : 85 - 93
  • [9] LDR IODINE-125 BRACHYTHERAPY AS BOOST IN CURATIVE INTENT RADIOTHERAPY OF PROSTATE CANCER
    Fekete, Z.
    Dordai, D.
    Kacso, G.
    Mocan, C.
    Dordai, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S385 - S385
  • [10] Multivariable model development for mortality after total salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S15 - S16
12345